Tanya O’Neal

489 total citations
11 papers, 302 citations indexed

About

Tanya O’Neal is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Tanya O’Neal has authored 11 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Tanya O’Neal's work include Antimicrobial Resistance in Staphylococcus (5 papers), Immunotherapy and Immune Responses (4 papers) and Prostate Cancer Treatment and Research (4 papers). Tanya O’Neal is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Immunotherapy and Immune Responses (4 papers) and Prostate Cancer Treatment and Research (4 papers). Tanya O’Neal collaborates with scholars based in United States, Israel and Poland. Tanya O’Neal's co-authors include Alena Jandourek, John S. Bradley, H. David Friedland, Christopher Cannavino, Bartosz Korczowski, Dirk Thye, Mohamad E. Allaf, Carolyn G. Chapman, Emmanuel S. Antonarakis and Angelo M. De Marzo and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tanya O’Neal

11 papers receiving 298 citations

Peers

Countries citing papers authored by Tanya O’Neal

Since Specialization

Citations

This map shows the geographic impact of Tanya O’Neal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya O’Neal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya O’Neal more than expected).

Fields of papers citing papers by Tanya O’Neal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya O’Neal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya O’Neal. The network helps show where Tanya O’Neal may publish in the future.

Co-authorship network of co-authors of Tanya O’Neal

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya O’Neal. A scholar is included among the top collaborators of Tanya O’Neal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya O’Neal. Tanya O’Neal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	627P Phase II neoadjuvant trial of the anti–B7-H3 antibody, enoblituzumab, in men with localized prostate cancer: Safety, efficacy and immune correlates 2021 ·Annals of Oncology ·Eugene Shenderov, Angelo De Marzo, Tamara L. Lotan, (unknown), Mohamad E. Allaf, Karim Boudadi, Carolyn G. Chapman, Tanya O’Neal, (unknown), Paul A. Moore, John Muth, (unknown), (unknown), S. Church, (unknown), (unknown), Christian P. Pavlovich, Charles G. Drake, Drew M. Pardoll, Emmanuel S. Antonarakis	2
2	T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer 2020 ·Clinical Cancer Research ·Aleksandar Obradović, Matthew C. Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross, Mohamad E. Allaf, Thomas R. Nirschl, David Liu, Carolyn G. Chapman, Tanya O’Neal, Haiyi Cao, Jennifer N. Durham, Güneş Güner, Javier Baena-Del Valle, Onur Ertunç, Angelo M. De Marzo, Emmanuel S. Antonarakis, Charles G. Drake	73
3	Phase II neoadjuvant and immunologic study of B7-H3 targeting with enoblituzumab in localized intermediate- and high-risk prostate cancer. 2018 ·Journal of Clinical Oncology ·Eugene Shenderov, Angelo M. De Marzo, Karim Boudadi, Mohamad E. Allaf, Hao Wang, Carolyn G. Chapman, Christian P. Pavlovich, Trinity J. Bivalacqua, Tanya O’Neal, Rana Harb, Rehab Abdallah, Charles G. Drake, Drew M. Pardoll, Emmanuel S. Antonarakis	14
4	Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy 2017 ·Oncotarget ·Ashley E. Ross, Robert M. Hughes, Stephanie Glavaris, Kamyar Ghabili, Ping He, Nicole M. Anders, Rana Harb, Jeffrey J. Tosoian, Luigi Marchionni, Edward M. Schaeffer, Alan W. Partin, Mohamad E. Allaf, Trinity J. Bivalacqua, Carolyn G. Chapman, Tanya O’Neal, Angelo M. De Marzo, Paula J. Hurley, Michelle A. Rudek, Emmanuel S. Antonarakis	24
5	Neoadjuvant randomized trial of degarelix (Deg) ± cyclophosphamide/GVAX (Cy/GVAX) in men with high-risk prostate cancer (PCa) undergoing radical prostatectomy (RP). 2017 ·Journal of Clinical Oncology ·Emmanuel S. Antonarakis, Marianna Zahurak, Edward M. Schaeffer, Alan W. Partin, Ashley E. Ross, Mohamad E. Allaf, Jeffrey J. Tosoian, Thomas R. Nirschl, Carolyn G. Chapman, Tanya O’Neal, Haiyi Cao, Jennifer N. Durham, Güneş Güner, (unknown), Onur Ertunç, Angelo M. De Marzo, Charles G. Drake	10
6	A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia 2016 ·The Pediatric Infectious Disease Journal ·Jeffrey L. Blumer, (unknown), Christopher Cannavino, Tanya O’Neal, Alena Jandourek, (unknown), John S. Bradley	36
7	A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection 2016 ·The Pediatric Infectious Disease Journal ·Bartosz Korczowski, (unknown), (unknown), Martín E. Stryjewski, Alena Jandourek, (unknown), Tanya O’Neal, John S. Bradley	34
8	A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone 2016 ·The Pediatric Infectious Disease Journal ·Christopher Cannavino, (unknown), Bartosz Korczowski, John S. Bradley, Tanya O’Neal, Alena Jandourek, H. David Friedland, Sheldon L. Kaplan	39
9	Playing a role in secondary prevention in the ED: longitudinal study of patients with asymptomatic elevated blood pressures following a brief education intervention: a pilot study 2015 ·Public Health ·Heather M. Prendergast, (unknown), Marina Del Rios, (unknown), R. J. Schulz, Tanya O’Neal	9
10	CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections 2012 ·Antimicrobial Agents and Chemotherapy ·H. David Friedland, Tanya O’Neal, Donald Biek, Paul B. Eckburg, (unknown), Lily Llorens, Alex Smith, Gary W. Witherell, (unknown), Dirk Thye	57
11	Prospective Study of the Wilson Severity-of-Illness Scoring System for Complicated Skin and Skin Structure Infections 2012 ·Antimicrobial Agents and Chemotherapy ·George H. Talbot, Tanya O’Neal, Anita Das, Dirk Thye	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact